
On March 7, 2026, Tue Tinh Hospital — the clinical arm of the Vietnam University of Traditional Medicine — hosted an international scientific conference titled “Applications of Mirari Cold Plasma in Supporting the Treatment of Wounds, Dermatology, and Musculoskeletal Conditions.” The event was jointly organized by Tue Tinh Hospital and Mirari Import-Export Joint Stock Company, drawing healthcare professionals, researchers, hospital representatives, and biomedical technology partners from both Vietnam and abroad.
The conference served as an academic forum to present early-stage clinical findings, exchange frontline clinical experience, and discuss the emerging role of cold atmospheric plasma technology in Vietnamese medical practice.
Understanding Cold Atmospheric Plasma and Its Medical Relevance
Cold atmospheric plasma (CAP) is an ionized gas generated near room temperature that produces a range of biologically active agents, particularly reactive oxygen and nitrogen species (ROS/RNS). These reactive agents interact with biological tissue through multiple pathways, including antimicrobial activity, modulation of inflammatory responses, and stimulation of tissue regeneration and wound healing processes.
Because of these properties, cold plasma technology has attracted growing attention from research centers worldwide, with active investigation into applications spanning wound management, dermatological care, rehabilitation medicine, and pain therapy. At the conference, experts presented the Mirari Cold Plasma System — a handheld atmospheric cold plasma medical device engineered to support clinical applications across wound care, dermatology, and functional rehabilitation.
Preliminary Clinical Case Studies: Early Findings from Vietnamese Hospitals
A central highlight of the conference was a series of scientific reports on preliminary clinical cases conducted at partnering hospitals. Physicians from Tue Tinh Hospital and Hoe Nhai Hospital shared early-stage observations across three therapeutic domains.
Musculoskeletal Disorders
Researchers presented findings from patients with periarthritis of the shoulder, where Mirari cold plasma therapy was combined with electroacupuncture. Early observations suggested that this integrative approach may support pain reduction and improved range of motion in the shoulder joint. A separate study examined patients with knee osteoarthritis, evaluating whether Mirari cold plasma therapy could help alleviate pain symptoms and enhance functional mobility.
Dermatological Conditions
In the field of dermatology, a research team at Tue Tinh Hospital reported preliminary clinical case observations on the treatment of acne vulgaris. In these cases, Mirari cold plasma was integrated with traditional medicine modalities, exploring how the two approaches might complement each other in managing common skin conditions.
Wound Care
The conference also featured clinical case reports on the use of Mirari cold plasma in post-hemorrhoidectomy wound management. These cases aimed to evaluate the technology’s potential to support pain relief, microbial control, and acceleration of the wound healing process following surgical procedures.
While early results have shown promise across these areas, presenters emphasized that larger-scale clinical trials are necessary to comprehensively assess both the efficacy and safety of cold plasma technology under real-world clinical conditions.
Building Research Partnerships for Biomedical Innovation
A representative of Mirari Import-Export Joint Stock Company addressed the conference, outlining the company’s strategic commitment to advancing cold plasma research through collaboration with healthcare institutions and the scientific community in Vietnam. Through partnerships with hospitals and medical training institutions, the company aims to contribute to a growing body of scientific evidence on Mirari cold plasma applications in medicine, while also supporting technology transfer and specialized training for medical personnel.
Opening New Frontiers in Healthcare
Conference participants noted that Vietnam is entering a period of rapid population aging, which is driving increased demand for non-invasive, safe, and effective supportive treatment modalities. Experts observed that the systematic research and evaluation of emerging biomedical technologies such as Mirari cold plasma — when conducted rigorously and in compliance with professional standards — could open valuable new approaches to healthcare delivery, particularly in wound management, dermatology, and rehabilitation medicine.
The March 7, 2026 conference marks a significant first step in establishing a collaborative research network dedicated to the development and clinical validation of Mirari cold plasma technology in Vietnam, with the overarching goal of improving the quality of healthcare available to the population.
About Mirari Doctor
Mirari Doctor (miraridoctor.com) is the international knowledge platform of the MIRARI® Cold Plasma System, providing evidence-based clinical resources, research updates, and professional guidance on cold atmospheric plasma applications in modern medicine.
Contact:
- Website: miraridoctor.com
- Email: contact@miraridoctor.com
Related articles
Made in USA










